Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EY, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP. McGorry PD, et al. Among authors: smesny s. JAMA Psychiatry. 2017 Jan 1;74(1):19-27. doi: 10.1001/jamapsychiatry.2016.2902. JAMA Psychiatry. 2017. PMID: 27893018 Free article. Clinical Trial.
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis.
Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Meyer BJ, Amminger GP. Alqarni A, et al. Among authors: smesny s. Schizophr Res. 2020 Dec;226:52-60. doi: 10.1016/j.schres.2019.08.033. Epub 2019 Oct 9. Schizophr Res. 2020. PMID: 31606244 Clinical Trial.
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis.
Amminger GP, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD. Amminger GP, et al. Among authors: smesny s. Biol Psychiatry. 2020 Feb 1;87(3):243-252. doi: 10.1016/j.biopsych.2019.08.030. Epub 2019 Sep 18. Biol Psychiatry. 2020. PMID: 31690495
Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
Smesny S, Milleit B, Hipler UC, Milleit C, Schäfer MR, Klier CM, Holub M, Holzer I, Berger GE, Otto M, Nenadic I, Berk M, McGorry PD, Sauer H, Amminger GP. Smesny S, et al. Mol Psychiatry. 2014 Mar;19(3):317-24. doi: 10.1038/mp.2013.7. Epub 2013 Mar 12. Mol Psychiatry. 2014. PMID: 23478748 Clinical Trial.
Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers.
Clark SR, Baune BT, Schubert KO, Lavoie S, Smesny S, Rice SM, Schäfer MR, Benninger F, Feucht M, Klier CM, McGorry PD, Amminger GP. Clark SR, et al. Among authors: smesny s. Transl Psychiatry. 2016 Sep 20;6(9):e897. doi: 10.1038/tp.2016.170. Transl Psychiatry. 2016. PMID: 27648919 Free PMC article.
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
Youn S, Phillips LJ, Amminger GP, Berger G, Chen EYH, de Haan L, Hartmann JA, Hickie IB, Lavoie S, Markulev C, McGorry PD, Mossaheb N, Nieman DH, Nordentoft M, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Smesny S, Thompson A, Verma S, Yuen HP, Yung AR, Nelson B. Youn S, et al. Among authors: smesny s. Schizophr Res. 2020 Feb;216:255-261. doi: 10.1016/j.schres.2019.11.047. Epub 2019 Dec 19. Schizophr Res. 2020. PMID: 31866077
Dynamic prediction of transition to psychosis using joint modelling.
Yuen HP, Mackinnon A, Hartmann J, Amminger GP, Markulev C, Lavoie S, Schäfer MR, Polari A, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Nelson B. Yuen HP, et al. Among authors: smesny s. Schizophr Res. 2018 Dec;202:333-340. doi: 10.1016/j.schres.2018.07.002. Epub 2018 Jul 7. Schizophr Res. 2018. PMID: 30539771 Clinical Trial.
The association between migrant status and transition in an ultra-high risk for psychosis population.
O'Donoghue B, Geros H, Sizer H, Addington J, Amminger GP, Beaden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Berger GE, Chen EYH, de Haan L, Hartmann JA, Hickie IB, Ising HK, Lavoie S, Lin A, Markulev C, Mathalon DH, McGlashan TH, Mifsud NG, Mossaheb N, Nieman DH, Nordentoft M, Perkins DO, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Seidman LJ, Smesny S, Thompson A, Tsuang MT, van der Gaag M, Verma S, Walker EF, Wood SJ, Woods SW, Yuen HP, Yung AR, McGorry PD, Nelson B. O'Donoghue B, et al. Among authors: smesny s. Soc Psychiatry Psychiatr Epidemiol. 2021 Jun;56(6):943-952. doi: 10.1007/s00127-020-02012-6. Epub 2021 Jan 5. Soc Psychiatry Psychiatr Epidemiol. 2021. PMID: 33399885
109 results